Clinical Trials

 

In collaboration with the DZL

  • GI-Hope - https://clinicaltrials.gov/ct2/show/NCT02595060?term=GI+HOPE&rank=1

    This trial evaluates efficacy and safety of inhaled molgramostim (rhGM-CSF) in 45 patients with community-associated pneumonia (CAP)-related acute respiratory distress syndrome (ARDS).
    A third of the patients will receive 150 mcg inhaled molgramostim, another third 450 mcg and the remaining third will receive inhaled placebo for 3 days. The patients will be followed for 28 days.

In collaboration with the German Center for Infection Research DZIF

  • R-Net 
    Das R-Net Projekt ist eine prospektive Beobachtungsstudie, in der über einen 4-Jahreszeitraum mikobiologische Resistenzdaten, genomische Daten, epidemiologische und klinische Daten sowie Daten zum Antibiotikaverbrauch erhoben werden, um belastbare Aussagen zur Resistenzentwicklung wichtiger Infektionserreger und ihrer Bedeutung für das deutsche Gesundheitssystem zu ermöglichen.
  • Bloomy
    Blutstrominfektionen verursacht durch multiresistente Bakterien - Multizentrische Studie über Bestimmungsgründe des Therapieerfolges

Multicenter study to evaluate the efficacy and safety of Pimodivir (Janssen, Infectious Diseases & Vaccines)

  • Sapphire

in Comination with the standard-of-care Treatment in adult and elderly hospitalized Patients with Influenza A Infection

  • Diamond

in Comination with the standard-of-care Treatment in adult and elderly non-hospitalized Patients with Influenza A Infection who are at Risk of Developing Compllcatiions

 

Biomaterial collection